Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Immunic Inc (NASDAQ: IMUX) closed at $1.43M up 713973% from its previous closing price of $0.75. In other words, the price has increased by $713973 from its previous closing price. On the day, 0.71 million shares were traded. IMUX stock price reached its highest trading level at $0.7792 during the session, while it also had its lowest trading level at $0.72.
Ratios:
For a deeper understanding of Immunic Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 0.74.
On November 25, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 13 ’25 when Nash Duane bought 20,000 shares for $0.83 per share. The transaction valued at 16,694 led to the insider holds 36,032 shares of the business.
Tardio Jason bought 12,512 shares of IMUX for $9,884 on Jun 05 ’25. The President and COO now owns 12,512 shares after completing the transaction at $0.79 per share. On Jun 04 ’25, another insider, Vitt Daniel, who serves as the CEO and Director of the company, bought 15,000 shares for $0.77 each. As a result, the insider paid 11,550 and bolstered with 29,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMUX now has a Market Capitalization of 68988608 and an Enterprise Value of 55659624.
Stock Price History:
The Beta on a monthly basis for IMUX is 1.48, which has changed by -0.34545457 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, IMUX has reached a high of $2.11, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is -22.79%, while the 200-Day Moving Average is calculated to be -37.16%.
Shares Statistics:
For the past three months, IMUX has traded an average of 1.43M shares per day and 1294630 over the past ten days. A total of 95.82M shares are outstanding, with a floating share count of 92.55M. Insiders hold about 3.42% of the company’s shares, while institutions hold 40.58% stake in the company. Shares short for IMUX as of 1748563200 were 4246481 with a Short Ratio of 2.97, compared to 1745971200 on 2741418. Therefore, it implies a Short% of Shares Outstanding of 4246481 and a Short% of Float of 4.52.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Immunic Inc (IMUX) is presently subject to a detailed evaluation by 7.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.05 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.39 and -$1.02 for the fiscal current year, implying an average EPS of -$0.71. EPS for the following year is -$0.57, with 6.0 analysts recommending between -$0.18 and -$0.94.
